Literature DB >> 21505347

Association between plasma leptin and blood pressure in two population-based samples of children and adolescents.

Anders Grøntved1, Jostein Steene-Johannessen, Iben Kynde, Paul W Franks, Jørn Wulf Helge, Karsten Froberg, Sigmund A Anderssen, Lars Bo Andersen.   

Abstract

OBJECTIVES: In this study we examined the association between leptin and blood pressure in a population-based study of Danish and Norwegian children and adolescents. Because of the putative bidirectional relationship between leptin and adiposity we formally tested (i) the mediating effect of body mass index in the association between leptin and blood pressure, and (ii) the mediating effect of leptin in the association between body mass index and blood pressure.
METHODS: To examine these aims we used a cross-sectional random sample of children and adolescents from Denmark and Norway (n = 1993) who had measures of leptin, anthropometry, blood pressure and other personal and biological risk factors for raised blood pressure available.
RESULTS: Both body mass index and leptin were positively associated with blood pressure (P < 0.001). The association with leptin was stronger in pre- and early-pubertal children compared to late- and post-pubertal adolescents (P < 0.01 for interaction). The association between leptin and blood pressure was almost completely mediated by body mass index, whereas the association between body mass index and blood pressure was modestly mediated by leptin.
CONCLUSION: Leptin was strongly associated with blood pressure, a relationship that to a large extent was mediated by body mass index. Conversely, the association between body mass index and blood pressure was only modestly mediated by leptin. This indicates that the influence of adiposity on blood pressure is also driven by other biological risk factors beyond leptin. Such factors could include insulin, glucose, and triglycerides although residual confounding also could account for the observed relationships.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21505347     DOI: 10.1097/HJH.0b013e328346d787

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

Review 1.  Hypertension and obesity: epidemiology, mechanisms and clinical approach.

Authors:  Lauren J Becton; Ibrahim F Shatat; Joseph T Flynn
Journal:  Indian J Pediatr       Date:  2012-06-05       Impact factor: 1.967

Review 2.  Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.

Authors:  Graziela Z Kalil; William G Haynes
Journal:  Hypertens Res       Date:  2011-11-03       Impact factor: 3.872

3.  Pro- and anti-inflammatory adipokines are associated with cardiometabolic risk markers in Brazilian schoolchildren.

Authors:  Mariana De Santis Filgueiras; Milene Cristine Pessoa; Josefina Bressan; Fernanda Martins de Albuquerque; Lara Gomes Suhett; Mariane Alves Silva; Juliana Farias de Novaes
Journal:  Eur J Pediatr       Date:  2021-04-09       Impact factor: 3.183

Review 4.  The emerging epidemic of hypertension in Asian children and adolescents.

Authors:  Chong Guk Lee
Journal:  Curr Hypertens Rep       Date:  2014-12       Impact factor: 5.369

Review 5.  The changing face of pediatric hypertension in the era of the childhood obesity epidemic.

Authors:  Joseph Flynn
Journal:  Pediatr Nephrol       Date:  2012-11-09       Impact factor: 3.714

6.  Leptin mediates the relationship between fat mass and blood pressure: The Hamamatsu School-based health study.

Authors:  Yuki Fujita; Katsuyasu Kouda; Kumiko Ohara; Harunobu Nakamura; Masayuki Iki
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

Review 7.  Obesity and Cardiometabolic Risk Factors: From Childhood to Adulthood.

Authors:  Dorota Drozdz; Julio Alvarez-Pitti; Małgorzata Wójcik; Claudio Borghi; Rosita Gabbianelli; Artur Mazur; Vesna Herceg-Čavrak; Beatriz Gonzalez Lopez-Valcarcel; Michał Brzeziński; Empar Lurbe; Elke Wühl
Journal:  Nutrients       Date:  2021-11-22       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.